questionsmedicales.fr
Composés hétérocycliques
Composés hétéromonocycliques
Furanes
Furanes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Exposition professionnelle
Toxicologie
Analyse de sang
Analyse d'urine
Marqueurs biologiques
Furanes
Évaluation des risques
Exposition professionnelle
Symptômes
5
Effets à long terme
Troubles neurologiques
Système respiratoire
Irritation
Système immunitaire
Exposition prolongée
Prévention
5
Prévention
Équipements de protection
Mesures de sécurité
Ventilation
Industrie alimentaire
Contrôle de la température
Réglementations
Exposition professionnelle
Formation
Risques professionnels
Traitements
5
Antidotes
Traitement symptomatique
Irritation cutanée
Traitement topique
Soins d'urgence
Évaluation médicale
Complications
5
Complications
Troubles respiratoires
Cancers
Potentiel cancérigène
Reproduction
Développement fœtal
Système nerveux
Neuropathies
Facteurs de risque
5
Travailleurs
Industrie chimique
Pollution de l'air
Industries
Antécédents médicaux
Maladies respiratoires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Furanes : Questions médicales les plus fréquentes",
"headline": "Furanes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Furanes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-26",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Furanes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétéromonocycliques",
"url": "https://questionsmedicales.fr/mesh/D006573",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétéromonocycliques",
"code": {
"@type": "MedicalCode",
"code": "D006573",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "4-Butyrolactone",
"alternateName": "4-Butyrolactone",
"url": "https://questionsmedicales.fr/mesh/D015107",
"about": {
"@type": "MedicalCondition",
"name": "4-Butyrolactone",
"code": {
"@type": "MedicalCode",
"code": "D015107",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anhydrides citraconiques",
"alternateName": "Citraconic Anhydrides",
"url": "https://questionsmedicales.fr/mesh/D002949",
"about": {
"@type": "MedicalCondition",
"name": "Anhydrides citraconiques",
"code": {
"@type": "MedicalCode",
"code": "D002949",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Darunavir",
"alternateName": "Darunavir",
"url": "https://questionsmedicales.fr/mesh/D000069454",
"about": {
"@type": "MedicalCondition",
"name": "Darunavir",
"code": {
"@type": "MedicalCode",
"code": "D000069454",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.303"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Furfural",
"alternateName": "Furaldehyde",
"url": "https://questionsmedicales.fr/mesh/D005662",
"about": {
"@type": "MedicalCondition",
"name": "Furfural",
"code": {
"@type": "MedicalCode",
"code": "D005662",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.355"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lasalocide",
"alternateName": "Lasalocid",
"url": "https://questionsmedicales.fr/mesh/D007832",
"about": {
"@type": "MedicalCondition",
"name": "Lasalocide",
"code": {
"@type": "MedicalCode",
"code": "D007832",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anhydrides maléiques",
"alternateName": "Maleic Anhydrides",
"url": "https://questionsmedicales.fr/mesh/D008299",
"about": {
"@type": "MedicalCondition",
"name": "Anhydrides maléiques",
"code": {
"@type": "MedicalCode",
"code": "D008299",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.520"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Monensin",
"alternateName": "Monensin",
"url": "https://questionsmedicales.fr/mesh/D008985",
"about": {
"@type": "MedicalCondition",
"name": "Monensin",
"code": {
"@type": "MedicalCode",
"code": "D008985",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Naftidrofuryl",
"alternateName": "Nafronyl",
"url": "https://questionsmedicales.fr/mesh/D009257",
"about": {
"@type": "MedicalCondition",
"name": "Naftidrofuryl",
"code": {
"@type": "MedicalCode",
"code": "D009257",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.620"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrofuranes",
"alternateName": "Nitrofurans",
"url": "https://questionsmedicales.fr/mesh/D009581",
"about": {
"@type": "MedicalCondition",
"name": "Nitrofuranes",
"code": {
"@type": "MedicalCode",
"code": "D009581",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "3-(2-(5-Nitro-2-furyl)vinyl)-1,2,4-oxadiazol-5-amine",
"alternateName": "5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",
"url": "https://questionsmedicales.fr/mesh/D013184",
"about": {
"@type": "MedicalCondition",
"name": "3-(2-(5-Nitro-2-furyl)vinyl)-1,2,4-oxadiazol-5-amine",
"code": {
"@type": "MedicalCode",
"code": "D013184",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N-(4-(5-Nitro-2-furyl)-1,3-thiazol-2-yl)formamide",
"alternateName": "FANFT",
"url": "https://questionsmedicales.fr/mesh/D005200",
"about": {
"@type": "MedicalCondition",
"name": "N-(4-(5-Nitro-2-furyl)-1,3-thiazol-2-yl)formamide",
"code": {
"@type": "MedicalCode",
"code": "D005200",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.290"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Furagine",
"alternateName": "Furagin",
"url": "https://questionsmedicales.fr/mesh/D005661",
"about": {
"@type": "MedicalCondition",
"name": "Furagine",
"code": {
"@type": "MedicalCode",
"code": "D005661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.308"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Furazolidone",
"alternateName": "Furazolidone",
"url": "https://questionsmedicales.fr/mesh/D005664",
"about": {
"@type": "MedicalCondition",
"name": "Furazolidone",
"code": {
"@type": "MedicalCode",
"code": "D005664",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.313"
}
}
},
{
"@type": "MedicalWebPage",
"name": "2-(Furan-2-yl)-3-(5-nitrofuran-2-yl)prop-2-énamide",
"alternateName": "Furylfuramide",
"url": "https://questionsmedicales.fr/mesh/D005668",
"about": {
"@type": "MedicalCondition",
"name": "2-(Furan-2-yl)-3-(5-nitrofuran-2-yl)prop-2-énamide",
"code": {
"@type": "MedicalCode",
"code": "D005668",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.330"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nifuratel",
"alternateName": "Nifuratel",
"url": "https://questionsmedicales.fr/mesh/D009545",
"about": {
"@type": "MedicalCondition",
"name": "Nifuratel",
"code": {
"@type": "MedicalCode",
"code": "D009545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.410"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrofurantoïne",
"alternateName": "Nitrofurantoin",
"url": "https://questionsmedicales.fr/mesh/D009582",
"about": {
"@type": "MedicalCondition",
"name": "Nitrofurantoïne",
"code": {
"@type": "MedicalCode",
"code": "D009582",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.566"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrofural",
"alternateName": "Nitrofurazone",
"url": "https://questionsmedicales.fr/mesh/D009583",
"about": {
"@type": "MedicalCondition",
"name": "Nitrofural",
"code": {
"@type": "MedicalCode",
"code": "D009583",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.691"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrovin",
"alternateName": "Nitrovin",
"url": "https://questionsmedicales.fr/mesh/D009610",
"about": {
"@type": "MedicalCondition",
"name": "Nitrovin",
"code": {
"@type": "MedicalCode",
"code": "D009610",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ranitidine",
"alternateName": "Ranitidine",
"url": "https://questionsmedicales.fr/mesh/D011899",
"about": {
"@type": "MedicalCondition",
"name": "Ranitidine",
"code": {
"@type": "MedicalCode",
"code": "D011899",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Furanes",
"alternateName": "Furans",
"code": {
"@type": "MedicalCode",
"code": "D005663",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anja Rahn",
"url": "https://questionsmedicales.fr/author/Anja%20Rahn",
"affiliation": {
"@type": "Organization",
"name": "Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: rahj@zhaw.ch."
}
},
{
"@type": "Person",
"name": "Chahan Yeretzian",
"url": "https://questionsmedicales.fr/author/Chahan%20Yeretzian",
"affiliation": {
"@type": "Organization",
"name": "Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: yere@zhaw.ch."
}
},
{
"@type": "Person",
"name": "Yinbo Wan",
"url": "https://questionsmedicales.fr/author/Yinbo%20Wan",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China."
}
},
{
"@type": "Person",
"name": "Haiyun Peng",
"url": "https://questionsmedicales.fr/author/Haiyun%20Peng",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China."
}
},
{
"@type": "Person",
"name": "Guisheng Deng",
"url": "https://questionsmedicales.fr/author/Guisheng%20Deng",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Immunophenotyping of pulmonary sarcomatoid carcinoma.",
"datePublished": "2022-10-20",
"url": "https://questionsmedicales.fr/article/36341325",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.976739"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immune infiltration and immunophenotyping in atrial fibrillation.",
"datePublished": "2023-01-04",
"url": "https://questionsmedicales.fr/article/36602538",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.18632/aging.204470"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immunophenotypic characterization of acute leukemias in Bahia, Brazil.",
"datePublished": "2023-01-06",
"url": "https://questionsmedicales.fr/article/36629681",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31744/einstein_journal/2023AO0117"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Immunophenotypic Profile of Healthy Human Bone Marrow.",
"datePublished": "2023-06-04",
"url": "https://questionsmedicales.fr/article/37481314",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cll.2023.04.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Describing IgA Myeloma: An Immunophenotypic and Molecular Approach.",
"datePublished": "2022-08-01",
"url": "https://questionsmedicales.fr/article/35882000",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétéromonocycliques",
"item": "https://questionsmedicales.fr/mesh/D006573"
},
{
"@type": "ListItem",
"position": 4,
"name": "Furanes",
"item": "https://questionsmedicales.fr/mesh/D005663"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Furanes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Furanes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Furanes",
"description": "Comment diagnostiquer une exposition aux furanes ?\nQuels tests sont utilisés pour détecter les furanes ?\nQuels symptômes indiquent une intoxication aux furanes ?\nY a-t-il des marqueurs biologiques pour les furanes ?\nComment évaluer le risque d'exposition aux furanes ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Immunophenotyping#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Furanes",
"description": "Quels sont les symptômes d'une intoxication aiguë aux furanes ?\nLes furanes provoquent-ils des effets à long terme ?\nComment les furanes affectent-ils le système respiratoire ?\nY a-t-il des symptômes spécifiques chez les travailleurs exposés ?\nLes furanes affectent-ils le système immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Immunophenotyping#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Furanes",
"description": "Comment prévenir l'exposition aux furanes ?\nQuelles mesures de sécurité doivent être mises en place ?\nLes furanes peuvent-ils être évités dans l'industrie alimentaire ?\nQuelles sont les réglementations concernant les furanes ?\nLes travailleurs doivent-ils être formés sur les furanes ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Immunophenotyping#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Furanes",
"description": "Quel est le traitement de l'intoxication aux furanes ?\nDes antidotes existent-ils pour les furanes ?\nComment traiter les irritations cutanées causées par les furanes ?\nLes soins d'urgence sont-ils nécessaires en cas d'exposition ?\nQuel suivi médical est recommandé après exposition ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Immunophenotyping#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Furanes",
"description": "Quelles complications peuvent survenir après exposition aux furanes ?\nLes furanes peuvent-ils causer des cancers ?\nComment les furanes affectent-ils la reproduction ?\nLes furanes peuvent-ils affecter le foie ?\nY a-t-il des effets sur le système nerveux ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Immunophenotyping#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Furanes",
"description": "Qui est le plus à risque d'exposition aux furanes ?\nLes fumeurs sont-ils plus à risque d'exposition ?\nLes enfants sont-ils plus vulnérables aux furanes ?\nQuels facteurs environnementaux augmentent le risque ?\nLes personnes ayant des antécédents médicaux sont-elles à risque ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Immunophenotyping#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une exposition aux furanes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques pour détecter des métabolites."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les furanes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour identifier les métabolites des furanes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication aux furanes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, des douleurs abdominales et des vertiges."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques pour les furanes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des marqueurs comme le 2-furylméthylcétone peuvent être mesurés dans les fluides corporels."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque d'exposition aux furanes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation des conditions de travail et des sources potentielles d'exposition est nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication aiguë aux furanes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent des maux de tête, des nausées, des irritations cutanées et respiratoires."
}
},
{
"@type": "Question",
"name": "Les furanes provoquent-ils des effets à long terme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition prolongée peut entraîner des effets chroniques comme des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Comment les furanes affectent-ils le système respiratoire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des irritations des voies respiratoires, des toux et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les travailleurs exposés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs peuvent présenter des symptômes comme des vertiges, des maux de tête et des troubles de la concentration."
}
},
{
"@type": "Question",
"name": "Les furanes affectent-ils le système immunitaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut altérer la réponse immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux furanes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité au travail."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité doivent être mises en place ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des systèmes de ventilation adéquats et des formations sur les risques chimiques sont essentiels."
}
},
{
"@type": "Question",
"name": "Les furanes peuvent-ils être évités dans l'industrie alimentaire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en contrôlant les températures de cuisson et en évitant les méthodes de cuisson à haute température."
}
},
{
"@type": "Question",
"name": "Quelles sont les réglementations concernant les furanes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réglementations strictes existent pour limiter l'exposition professionnelle et environnementale."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés sur les furanes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et les mesures de sécurité est cruciale pour les travailleurs."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de l'intoxication aux furanes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste à retirer la source d'exposition et à gérer les symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les furanes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique et de soutien."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées par les furanes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de rincer la zone affectée et d'appliquer des crèmes apaisantes ou corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires en cas d'exposition ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en cas de symptômes graves, une évaluation médicale urgente est nécessaire."
}
},
{
"@type": "Question",
"name": "Quel suivi médical est recommandé après exposition ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est conseillé pour surveiller les effets à long terme et la santé générale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition aux furanes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles respiratoires chroniques et des effets neurologiques."
}
},
{
"@type": "Question",
"name": "Les furanes peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Comment les furanes affectent-ils la reproduction ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition peut entraîner des effets néfastes sur la reproduction et le développement fœtal."
}
},
{
"@type": "Question",
"name": "Les furanes peuvent-ils affecter le foie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition peut entraîner des lésions hépatiques et des troubles fonctionnels du foie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets sur le système nerveux ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut causer des troubles neurologiques, y compris des neuropathies."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition aux furanes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et alimentaire sont les plus exposés aux furanes."
}
},
{
"@type": "Question",
"name": "Les fumeurs sont-ils plus à risque d'exposition ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter l'exposition aux furanes présents dans la fumée de cigarette."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables aux furanes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques des furanes en raison de leur développement."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux augmentent le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution de l'air et la proximité d'industries émettrices de furanes augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes ayant des antécédents médicaux sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des antécédents de maladies respiratoires ou hépatiques sont plus à risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: rahj@zhaw.ch.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: yere@zhaw.ch.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China.
Key Laboratory of the Assembly and Application of Organic Functional Molecules of Hunan Province, Hunan Normal University, Changsha 410081, China.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China.
Key Laboratory of the Assembly and Application of Organic Functional Molecules of Hunan Province, Hunan Normal University, Changsha 410081, China.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China.
Key Laboratory of the Assembly and Application of Organic Functional Molecules of Hunan Province, Hunan Normal University, Changsha 410081, China.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
UR Molecular Systems, Department of Chemistry, University of Liège 4000 Liège Belgium fremacle@uliege.be.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Manchester Manchester M13 9PL UK.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
UR Molecular Systems, Department of Chemistry, University of Liège 4000 Liège Belgium fremacle@uliege.be.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
UR Molecular Systems, Department of Chemistry, University of Liège 4000 Liège Belgium fremacle@uliege.be.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
School of Chemical and Materials Sciences, Indian Institute of Technology Goa, GEC Campus Farmagudi Goa-403401 India rishikesh.narayan@iitgoa.ac.in.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
School of Chemical and Materials Sciences, Indian Institute of Technology Goa, GEC Campus Farmagudi Goa-403401 India rishikesh.narayan@iitgoa.ac.in.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
School of Chemical and Materials Sciences, Indian Institute of Technology Goa, GEC Campus Farmagudi Goa-403401 India rishikesh.narayan@iitgoa.ac.in.
School of Interdisciplinary Life Sciences, Indian Institute of Technology Goa GEC Campus, Farmagudi Goa-403401 India.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Department of Food Science and Biotechnology, Dongguk University-Seoul, 32, Dongguk-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 400-820 Republic of Korea.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
Department of Food Chemistry and Analytical Chemistry (170a), Institute of Food Chemistry, University of Hohenheim, 70599 Stuttgart, Germany.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
Chemisches und Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weißenburger Straße 3, 76187 Karlsruhe, Germany.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
Department of Food Chemistry and Analytical Chemistry (170a), Institute of Food Chemistry, University of Hohenheim, 70599 Stuttgart, Germany. Electronic address: claudia.oellig@uni-hohenheim.de.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
Institute of Physical Chemistry, Karlsruhe Institute of Technology (KIT), Kaiserstr. 12, 76131 Karlsruhe, Germany.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom.
National Centre for Atmospheric Science, School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom.
Publications dans "Furanes" :
Previous studies have suggested that patients with pulmonary sarcomatoid carcinoma (PSC)may benefit from immune checkpoint inhibitors (ICIs); however, relevant data are lacking. This study aimed to es...
A retrospective analysis of pathologically confirmed PSC cases from two centers was performed from January 2009 to May 2021. According to the infiltration of CD8+ T cells in different spatial regions,...
A total of 32 patients with PSC were included in the final analysis. Of these patients, 65.6% (21/32), 15.6% (5/32), and 18.8% (6/32) were classified as immune-inflamed, immune-excluded, and immune-de...
Patients with PSC are characterized by immune-inflamed type and type I (PD-L1+/CD8+, adaptive immune resistance), explaining the intrinsic reasons for their high response rate to immunotherapy....
Atrial fibrillation (AF) is a relatively common arrhythmia in clinical practice. Although significant progress has been achieved in the treatment of AF and its associated complications, research on AF...
To characterize the immunophenotypic profile of acute leukemias in the population of the state of Bahia, Brazil....
This is a descriptive, retrospective study. From 2014 to 2018, 796 new cases of acute leukemia were evaluated. The data were obtained from analysis of reports and records of tests performed by flow cy...
Most cases were diagnosed as acute myeloid leukemia and 42.7% as acute lymphoblastic leukemia. Significant differences were found in expression of markers in acute leukemias when age groups were compa...
Significant differences were found as to several antigens when comparing adults and children, and these findings may contribute to future studies correlating the phenotypic profile to genetic characte...
Flow cytometry enables multiparametric characterization of hematopoietic cell immunophenotype. Deviations from normal immunophenotypic patterns comprise a cardinal feature of many hematopoietic neopla...
Plasma cell myeloma (PCM) is defined as a clonal disease of terminally differentiated plasma cells that secrete immunoglobulin. The biologic underpinnings of IgA-type multiple myeloma's (IgAMM) aggres...
ASD reconstructions are a major, sterile traumatic insult, likely causing perturbations to the immune systems. The immune response to surgery is associated with outcomes. The purpose of this study was...
Consecutive patients undergoing ASD surgery were approached and enrolled. Peripheral blood was drawn before incision, 4 h after, and 24 h after incision. Blood was stabilized and comprehensive flow cy...
Thirteen patients were enrolled; 11(85%) F, 65.4 years (± 7.5), surgical duration 418 ± 83 min, EBL 1928 ± 1253 mL. Hierarchical clustering and PCA found consistent time from incision-dependent change...
Despite surgery and patient heterogeneity, we identified an immune signature associated with the sterile trauma of ASD surgery. Circulating leukocyte populations change in composition and signaling pr...
We aimed to provide an autophagy-related signature to seek immunophenotyping biomarkers in osteoarthritis (OA)....
Microarray expression profiling of OA subchondral bone samples and screening of an autophagy database for autophagy-related differentially expressed genes (au-DEGs) between OA and normal samples were ...
We screened 754 au-DEGs between OA and control samples, and co-expression networks were constructed using au-DEGs. Three OA-related autophagy hub genes (HSPA5, HSP90AA1, and ITPKB) were identified. Ba...
Three autophagy-related markers of OA were identified using bioinformatics methods, and these markers may be useful for the autophagy-related immunophenotyping of OA. The present data may facilitate t...
Prompt diagnosis of acute promyelocytic leukemia (APL) is critical for patient care. In this study, we aimed to characterize the immunophenotype of APL and explore immunophenotypic difference between ...
Eighty-five cases were collected, including 47 APL, 26 NPM1-mutated acute myeloid leukemia (AML) and 12 KMT2A-rearranged AML with an APL-like immunophenotype. Immunophenotypes were analyzed using flow...
APL showed four distinct patterns (designated a-d) based on CD45/SSC plots. Blasts in patterns a-c showed high side scatter, whereas blasts in pattern d had low side scatter and were located in the tr...
APL and its immunophenotypic mimics share some immunophenotypic similarities but can be distinguished by CD2, CD13, CD34, CD64, and MPO....
Acute myeloid leukemia (AML) with RAM immunophenotype is a distinct subtype of AML, as described by the Children's Oncology Group (COG), with characteristic morphological and immunophenotypic properti...
Seven cases with the characteristic RAM immunophenotype were identified in this retrospective analysis of newly diagnosed pediatric AML cases from January 2019 to December 2021. Herein, we have critic...
Of 302 cases of pediatric AML (age <18 years), seven cases (2.3%) with the distinct RAM phenotype were observed, with age ranging from 9 months to 5 years. Two patients were misdiagnosed earlier as sm...
AML with RAM immunophenotype, a distinct form of pediatric AML with a poor prognosis, may pose a diagnostic challenge if presented as a soft tissue mass. A comprehensive immunophenotypic evaluation, i...
Tγδ large granular lymphocyte leukemia (Tγδ LGLL) is a rare lymphoproliferative disease, scantily described in literature. A deep-analysis, in an initial cohort of 9 Tγδ LGLL compared to 23 healthy co...